Sarcopenic obesity study in adults
Part of Hormones & metabolism clinical trials.
This study looks at a condition called sarcopenic obesity, where people with obesity also have low muscle mass. It aims to find out how common it is and what causes it, by following patients over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have obesity with a BMI over 30.
- You are a clinical nutrition patient receiving a metabolic assessment.
- You do not have cancer or a severe chronic disease like kidney, liver, or lung failure.
- You can walk without help.
- You are not pregnant or breastfeeding.
- You have not taken part in the OBESAR study before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether doctors can spot “low muscle” (sarcopenia) in everyday clinic care for people with ovarian or endometrial cancer who are planning to start chemotherapy. It may help your care team identify muscle loss early and potentially support better treatment planning.
This study looks at how common it is to have both COPD (a chronic lung disease) and sarcopenic obesity (loss of muscle with excess body fat). By joining, you'll help doctors understand this condition better and may get a full health check-up.
This study looks at the link between muscle loss (sarcopenia) and obesity in older adults. It aims to understand why some older people who are overweight or obese also lose muscle strength and function, and how this affects recovery after hip surgery.
This study tests a new tool to diagnose muscle loss in people with obesity. It may help doctors better identify and treat this condition.
This trial tests a new care approach for older adults who have both excess body fat and muscle loss (sarcopenic obesity). The goal is to help improve muscle strength, physical function, and body composition.
This study looks at the bacteria in your gut (the microbiome) to understand how they relate to obesity and muscle loss. Researchers will collect stool samples to analyze the gut bacteria, which may help find new ways to treat metabolic diseases.
Hear when a new Obesity and Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.